← Back to News
News  ·  Cavulus Perspective

The Medicare Access & CHIP Reauthorization Act | MACRA and Medigap Policies

Share
The Medicare Access & CHIP Reauthorization Act | MACRA and Medigap Policies

We’ve been monitoring the rollout of various requirements tucked inside MACRA: The Medicare Access & CHIP Reauthorization Act of 2015. In regards to Medicare marketing and sales, the most significant is the ban on Medicare Supplement/Medigap policies that offer first-dollar coverage, beginning in 2020.

What You Need To Know
In short, starting in 2020, Medigap carriers can no longer offer two of their most popular plans, types C & F, to newly eligible beneficiaries. Existing membership in these plans will be grandfathered. However, with no new membership coming into plans C & F, the basic laws of underwriting dictate that cost pressure will force higher premiums for membership that remains. From our perspective, the Medicare Advantage market will have access to millions of newly eligible beneficiaries who may have been inclined to enroll in a Medigap plan, as well as an opportunity to encourage switchers who grow dissatisfied with higher Plan C/F premiums, or the lower benefit offering in Plan G.

What You Need To Do
If you haven’t incorporated the Medigap opportunity into your 2018 AEP strategy, you’re behind. Positioning has already begun and competition will only be more fierce in 2019 and 2020. Here are a few key questions to get you started:

If you’d like to discuss in more detail, please contact us at info@cavulus.com or 1-800-760-6915.

Ready to see what Cavulus can do?

We’d welcome the conversation — no deck, no hard sell.

Get in touch →